alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Drug Enforcement Administration 

      ( print page 61160)    
                    By Notice dated June 6, 2005 and published in the                     **Federal Register**                     on June 13, 2005, (70 FR 34152), Boehringer Ingelheim Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Phenylacetone (8501), a basic class of controlled substance listed in Schedule II.                 

The company plans to import the listed controlled substance to bulk manufacturer amphetamine. 

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Boehringer Ingelheim Chemicals, Inc. to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Boehringer Ingelheim Chemicals, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. 

Dated: October 12, 2005. 

Joseph T. Rannazzisi, 

Acting Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. 

[FR Doc. 05-20950 Filed 10-19-05; 8:45 am] 

BILLING CODE 4410-09-P
In the MATTER OF: J.W.

No. COA17-1278

Court of Appeals of North Carolina.

Filed: May 15, 2018

AFFIRMED.
##### 



EXECUTED as of March 12, 2008./s/ Edward F. Crawford

Edward F. CrawfordChief
Executive Officer, Chairman of the Board and Director
    
    
    
    /s/ Richard P. Elliott

Richard P. Elliott, Vice President and Chief Financial Officer/s/ Matthew V. Crawford

Matthew V. Crawford
    
    
    
    /s/ Dan T. Moore

Dan T. Moore, DirectorPresident, Chief Operating Officer, and Director/s/ Patrick V. Auletta

Patrick V. Auletta, Director
    
    
    
    /s/ Ronna Romney

Ronna Romney, Director/s/ Kevin R. Greene

Kevin R. Greene, Director
    
    
    
    /s/ James W. Wert

James W. Wert, Director
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health 

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, Cancer Sample Preparation/Cancer Detection.                    

*Date:*                         November 2, 2005.                    

*Time:*                         9 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878.                    

*Contact Person:*                         Thomas M. Vollberg, PhD, Scientific Review Administrator, Special Review And Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 7142, Bethesda, MD 20892, 301/594-9584,                         *volbert@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: October 4, 2005.

Anthony M. Coelho, Jr.,

Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 05-20749  Filed 10-17-05; 8:45 am]

BILLING CODE 4140-01-M
#### STATE OF NORTH CAROLINA v. WILLIAM UPTON

No. 7220SC820

(Filed 20 December 1972)

Appeal by defendant from *Lupton, Judge,*24 July 1972 Criminal Session, Stanly Superior Court.

Defendant was charged in a bill of indictment, proper in form with felonius escape from the lawful custody of the Superintendent of Unit 6540, Stanly County Subsidiary of the North Carolina Department of Correction, defendant being lawfully *167confined therein and serving a sentence for armed robbery and a sentence for escape. At trial defendant, orally and in writing, tendered a plea of guilty as charged. After due inquiry and adjudging that the plea was freely, understandingly and voluntarily made, without undue influence, compulsion or duress, and without promise of leniency, the court accepted the plea. From judgment imposing prison sentence, defendant appealed.

*Attorney General Robert Morgan by Charles A. Lloyd, Assistant Attorney General, for the State.*

*Brown, Brown & Brown by Fred Stokes for defendant appellant.*

BRITT, Judge.

Conceding that he can find no error in the record in this case, defendant’s court appointed counsel asks that we determine if there is error. We have carefully reviewed the record on appeal and perceive no prejudicial error.

The judgment appealed from is

Affirmed.

Judges Parker and Vaughn concur.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Education

# FOR FURTHER INFORMATION CONTACT:

                         Carla White, International Education Programs Service, U.S. Department of Education, 1990 K Street, NW., suite 6000, Washington, DC 20006-8521. Telephone: (202) 502-7631 or via Internet:                         *OPE_NRC-FLAS@ed.gov.*

If you use a telecommunications device for the deaf (TDD), you may call the Federal Relay Service (FRS) at 1-800-877-8339. 

Individuals with disabilities may obtain this document in an alternative format (e.g., Braille, large print, audiotape, or computer diskette) on request to the program contact persons listed in this section. 

## VIII. Other Information 

*Electronic Access to This Document:*                         You may view this document, as well as all other documents of this Department published in the                         **Federal Register**                        , in text or Adobe Portable Document Format (PDF) on the Internet at the following site:                         *www.ed.gov/​news/​fedregister.*

To use PDF you must have Adobe Acrobat Reader, which is available free at this site. If you have questions about using PDF, call the U.S. Government Printing Office (GPO), toll free, at 1-888-293-6498; or in the Washington, DC area at (202) 512-1530. 

# Note:

                            The official version of this document is the document published in the                             **Federal Register**                            . Free Internet access to the official edition of the                             **Federal Register**                             and the Code of Federal Regulations is available on GPO Access at:                             *www.gpoaccess.gov/​nara/​index.html.*

Dated: October 11, 2005. 

Sally L. Stroup, 

Assistant Secretary for Postsecondary Education. 

[FR Doc. 05-20625 Filed 10-13-05; 8:45 am] 

BILLING CODE 4000-01-P
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Antitrust Division

                    Notice is hereby given that, on December 22, 2004, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301*et seq.*                     (“the Act”), the AAF Association, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, MESoft, Burbank, CA; and XVUE Ltd., Artemida-Attika, Greece have been added as parties to this venture. Also, Nucoda, London, United Kingdom has withdrawn as a party to this venture. In addition, BBC Technology has changed its name to Siemens Business Services, San Jose, CA.                

No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and AAF Association, Inc. intends to file additional written notification disclosing all changes in membership. 

                    On March 28, 2000, AAF Association, Inc. filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the                     **Federal Register**                     pursuant to section 6(b) of the Act on June 29, 2000 (65 FR 40127).                

                    The last notification was filed with the Department on September 17, 2004. A notice was published in the                     **Federal Register**                     pursuant to section 6(b) of the Act on November 29, 2004 (69 FR 69391).                 

Dorothy B. Fountain,

Deputy Director of Operations, Antitrust Division.

[FR Doc. 05-1989  Filed 2-1-05; 8:45 am]

BILLING CODE 4410-11-M
Exhibit 32.1

CERTIFICATION PURSUANT TO  18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Gramercy Capital Corp. (the "Company") on Form 10-Q as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Roger M. Cozzi, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



/s/ ROGER M. COZZI Name:  Roger M. Cozzi
Title:Chief Executive Officer


Date:
August 10, 2009

---



QuickLinks
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Agriculture

###### Forest Service

# AGENCY:

Forest Service, USDA.

# ACTION:

Notice of meeting. 

# SUMMARY:

Pursuant to the authorities in the Federal Advisory Committee Act (Public Law 92-463) and under the Secure Rural Schools and Community Self-Determination Act of 2000 (Public Law 106-393), the Boise and Payette National Forests' Southwest Idaho Resource Advisory Committee will conduct a business meeting, which is open to the public.

# DATES:

Wednesday, October 19, 2005, beginning at 10:30 a.m.

# ADDRESSES:

Idaho Counties Risk Management Program Building, 3100 South Vista Avenue, Boise, Idaho.

# FOR FURTHER INFORMATION CONTACT:

                        Doug Gochnour, Designated Federal Officer, at (208) 392-6681 or e-mail                         *dgochnour@fs.fed.us.*

# SUPPLEMENTARY INFORMATION:

Agenda topics will include review and approval of project proposals, and is an open public forum.

Dated: October 6, 2005.

Suzanne C. Rainville,

Deputy Forest Supervisor, Boise National Forest.

[FR Doc. 05-20487 Filed 10-11-05; 8:45 am]

BILLING CODE 3410-11-M
#### Larry SEXTON, Appellant, v. STATE of Florida, Appellee.

No. 4D02-3089.

District Court of Appeal of Florida, Fourth District.

Aug. 27, 2003.

Larry Sexton, Okeechobee, pro se.

Charles J. Crist, Jr., Attorney General, Tallahassee, and Don M. Rogers, Assistant Attorney General, West Palm Beach, for appellee.

PER CURIAM.

Larry Sexton timely appeals from his June 28, 2002 resentencing, which effectively denied his motion for postconviction relief. We affirm. Sexton expressly waived all postconviction challenges in court and on the record before his last sentencing. This overcomes all of Sexton’s claims, including his argument that the trial court erred in relying on an allegedly incomplete transcript of his 1997 sentencing to determine the basis of his original plea agreement.

AFFIRMED.

WARNER, STEVENSON and GROSS, JJ., concur.
**Exhibit31.1**

**CERTIFICATIONPURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, John P. Longenecker,Ph.D., certify that:

1.             I have reviewed this report on Form 10-Q of Favrille,Inc.;

2.             Based on my knowledge, this report does not contain anyuntrue statement of a material fact or omit to state a material fact necessaryto make the statements made, in light of the circumstances under which suchstatements were made, not misleading with respect to the period covered by thisreport;

3.             Based on my knowledge, the financial statements, andother financial information included in this report, fairly present in allmaterial respects the financial condition, results of operations and cash flowsof the registrant as of, and for, the periods presented in this report;

4.             The registrant’s other certifying officer(s) and I areresponsible for establishing and maintaining disclosure controls and procedures(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrantand have:

(a) Designed such disclosurecontrols and procedures, or caused such disclosure controls and procedures tobe designed under our supervision, to ensure that material information relatingto the registrant, including its consolidated subsidiaries, is made known to usby others within those entities, particularly during the period in which thisreport is being prepared;

(b) Evaluated theeffectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

(c) Disclosed in thisreport any change in the registrant’s internal control over financial reportingthat occurred during registrant’s most recent fiscal quarter (the registrant’sfourth quarter in the case of an annual report) that has materially affected,or is reasonably likely to materially affect, the registrant’s internal controlover financial reporting; and

5.             The registrant’s other certifying officer(s) and I havedisclosed, based on our most recent evaluation of internal control overfinancial reporting, to the registrant’s auditors and the audit committee ofregistrant’s board of directors (or persons performing the equivalent functions):

(a) All significantdeficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and report financialinformation; and

(b) Any fraud, whether ornot material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting.

Date: May 11, 2007
| /s/ John P. Longenecker               |     |     |
|---------------------------------------|----------|----------|
| John P. Longenecker, Ph.D.            |     |
| President and Chief Executive Officer |     |     |
| *(Principal Executive Officer)*       | * * | * * |
|                                       |          |          |  |

 

----
[Federal Register Volume 70, Number 202 (Thursday, October 20, 2005)]
[Notices]
[Page 61144]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-21020]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel Review of Conference Grants (R13s)
    Date: November 8-9, 2005.
    Time: 8 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call)
    Contact Person: Deborah P. Beebe, Director, Division of 
Extramural Affairs, National Heart, Lung, and Blood Institute, NIH, 
Two Rockledge Center, Room 1700, 6701 Rockledge Drive, Bethesda, MD 
20892, 301/435-0260, <a href="/cdn-cgi/l/email-protection#41232424232425012f292d23286f2f28296f262e37"><span class="__cf_email__" data-cfemail="95f7f0f0f7f0f1d5fbfdf9f7fcbbfbfcfdbbf2fae3">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.937, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: October 11, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-21020 Filed 10-19-05; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>